Reversal of fetal benzodiazepine intoxication using flumazenil
M. Stahl,Pia Saldeen,E. Vinge
DOI: https://doi.org/10.1111/j.1471-0528.1993.tb15221.x
1993-02-01
British Journal of Obstetrics and Gynaecology
Abstract:A 22 year old primipara at 36 weeks gestation was admitted to the emergency unit after the intake of 50 to 60 five mg tablets of diazepam. There were no indications of tricyclic antidepressants or other drugs. On arrival at 7:30 a.m., 3.5 h following drug intake, she was somnolent but responded adequately when addressed. Blood pressure was 100/70 mmHg. The ECG was normal (QRS duration 0.84 s) apart from sinus tachycardia (103 beatslmin). Following gastric lavage which yielded some tablet rests, activated charcoal was administered. Approximately 7 h after tablet ingestion the serum levels of diazepam, oxazepam, and N-desmethyldiazepam were 1.9, 0.8 and 0-9 pmoV1 respectively. On admission to the delivery ward at 11:OO a.m., the cardiotocogram (CTG, abdominal recording) showed a basal frequency of 130 to 135 beats/min with decreased variability and absence of accelerations. This pattern remained unchanged for 2 h. During the next 2 h, the CTG exhibited an aggravation which included a tendency towards tachycardia (160 beatdmin) and occasional decelerations (Fig. 1). Doppler flow velocity waveforms in the descending aorta and the umbilical and carotid arteries of the fetus were normal. To differentiate between fetal asphyxia and an influence of benzodiazepines, the woman was given intravenously 0.3 mg of flumazenil (Lanexatm, Roche, Switzerland). Five minutes later she was awake, and on the CTG accelerations, and subsequently, an increased variability appeared (Fig. 2). The CTG was recorded three times, 1 to 2.5 h each time during the remaining part of the day and into the night: a normal ‘reactive’ pattern was exhibited. The woman showed no obvious signs of resedation in the afternoon or evening and the last CTG recording indicating a normal fetal status ended at approximately 3:40 a.m. At 6:20 a.m., the CTG again exhibited a decreased variability without accelerations, a pattern that persisted for 4 h (Fig. 3). Moreover, in the morning the woman was drowsy. Once more, 0.3 mg flumazenil was given intravenously, whereby she awakened, and the CTG was rapidly normalised (Fig. 4). All subsequent recordings were normal, and she was eventually discharged from the clinic after 7 days of observation. No adverse effects or withdrawal symptoms were noted following the flumazenil injections.